Entity Public Float of Immunovant, Inc. from 30 Sep 2019 to 30 Sep 2024

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: Immunovant, Inc. quarterly Entity Public Float in USD history and change rate from 30 Sep 2019 to 30 Sep 2024.
Immunovant, Inc. Entity Public Float for the quarter ending 30 Sep 2024 was $1,866,600,000, a 14% decline year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$1,866,600,000	-$310,300,000	-14%	30 Sep 2024	10-K	29 May 2025	2025	FY
Q3 2023	$2,176,900,000	+$1,938,000,000	+811%	30 Sep 2023	10-K	29 May 2024	2024	FY
Q3 2022	$238,900,000	-$108,100,000	-31%	30 Sep 2022	10-K	22 May 2023	2023	FY
Q3 2021	$347,000,000	-$1,113,500,000	-76%	30 Sep 2021	10-K	08 Jun 2022	2022	FY
Q3 2020	$1,460,500,000	+$1,345,200,000	+1167%	30 Sep 2020	10-K	01 Jun 2021	2020	FY
Q3 2019	$115,300,000			30 Sep 2019	10-K	29 Jun 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.